These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 21920845)

  • 21. MuSK-Ab positive myasthenia: not always grave.
    Zouvelou V; Stamboulis E; Skriapa L; Tzartos SJ
    J Neurol Sci; 2013 Aug; 331(1-2):150-1. PubMed ID: 23706725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ocular involvement in MuSK antibody-positive myasthenia gravis].
    Bau V; Hanisch F; Hain B; Zierz S
    Klin Monbl Augenheilkd; 2006 Jan; 223(1):81-3. PubMed ID: 16418940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged improvement after rituximab: two cases of resistant muscle-specific receptor tyrosine kinase + myasthenia gravis.
    Burusnukul P; Brennan TD; Cupler EJ
    J Clin Neuromuscul Dis; 2010 Dec; 12(2):85-7. PubMed ID: 21386776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
    Saulat B; Maertens P; Hamilton WJ; Bassam BA
    Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
    [No Abstract]   [Full Text] [Related]  

  • 25. MuSK antibody-positive, seronegative myasthenia gravis in Korea.
    Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A
    J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MuSK-positive myasthenia gravis is rare in the Polish population.
    Kostera-Pruszczyk A; Kamińska A; Dutkiewicz M; Emeryk-Szajewska B; Strugalska-Cynowska MH; Vincent A; Kwieciński H
    Eur J Neurol; 2008 Jul; 15(7):720-4. PubMed ID: 18494794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-MuSK myasthenia gravis with prolonged remission.
    Bouwyn JP; Magnier P; Bédat-Millet AL; Ahtoy P; Maltête D; Lefaucheur R
    Neuromuscul Disord; 2016 Jul; 26(7):453-4. PubMed ID: 27161384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Myasthenia gravis induced by autoantibodies against MuSK].
    Shigemoto K; Konishi T; Ohta M
    Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete stable remission and autoantibody specificity in myasthenia gravis.
    Baggi F; Andreetta F; Maggi L; Confalonieri P; Morandi L; Salerno F; Bernasconi P; Montomoli C; Barberis M; Mantegazza R; Antozzi C
    Neurology; 2013 Jan; 80(2):188-95. PubMed ID: 23255823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience.
    Pasnoor M; Wolfe GI; Nations S; Trivedi J; Barohn RJ; Herbelin L; McVey A; Dimachkie M; Kissel J; Walsh R; Amato A; Mozaffar T; Hungs M; Chui L; Goldstein J; Novella S; Burns T; Phillips L; Claussen G; Young A; Bertorini T; Oh S
    Muscle Nerve; 2010 Mar; 41(3):370-4. PubMed ID: 19882635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
    Deymeer F; Gungor-Tuncer O; Yilmaz V; Parman Y; Serdaroglu P; Ozdemir C; Vincent A; Saruhan-Direskeneli G
    Neurology; 2007 Feb; 68(8):609-11. PubMed ID: 17310034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG.
    Hatanaka Y; Hemmi S; Morgan MB; Scheufele ML; Claussen GC; Wolfe GI; Oh SJ
    Neurology; 2005 Nov; 65(9):1508-9. PubMed ID: 16275854
    [No Abstract]   [Full Text] [Related]  

  • 33. Myasthenia gravis with antibodies to MuSK: an update.
    Evoli A; Alboini PE; Damato V; Iorio R; Provenzano C; Bartoccioni E; Marino M
    Ann N Y Acad Sci; 2018 Jan; 1412(1):82-89. PubMed ID: 29266255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient neonatal myasthenia gravis due to a mother with ocular onset of anti-muscle specific kinase myasthenia gravis.
    Lee JY; Min JH; Han SH; Han J
    Neuromuscul Disord; 2017 Jul; 27(7):655-657. PubMed ID: 28495046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical aspects of MuSK antibody positive seronegative MG.
    Sanders DB; El-Salem K; Massey JM; McConville J; Vincent A
    Neurology; 2003 Jun; 60(12):1978-80. PubMed ID: 12821744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-MuSK-positive myasthenia gravis diagnosed during pregnancy: new challenges for an old disease?
    Neves AR; Monteiro P; Matos A; Santos Silva I
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25564591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with patients with anti-MUSK antibody positive myasthenia gravis.
    Sundar U; Shaunbhag P; Lakkas Y; Shrivastava M; Shah A; Vaidya M; Asole D
    J Assoc Physicians India; 2010 Oct; 58():640-2. PubMed ID: 21510119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy.
    Kostera-Pruszczyk A; Kwiecinski H
    J Neurol; 2009 Oct; 256(10):1780-1. PubMed ID: 19548060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longstanding and Refractory Anti-Muscle Specific Tyrosine Kinase Antibody-Associated Myasthenia Gravis (Anti-MuSK-MG) in a Child Successfully Treated with Rituximab.
    Weger S; Appendino JP; Clark IH
    J Binocul Vis Ocul Motil; 2019; 69(1):26-29. PubMed ID: 30811277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rituximab in the treatment of MuSK antibody-positive myasthenia gravis.
    Stein B; Bird SJ
    J Clin Neuromuscul Dis; 2011 Mar; 12(3):163-4. PubMed ID: 21321497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.